Matches in DBpedia 2016-04 for { <http://dbpedia.org/resource/BMS-955176> ?p ?o }
Showing triples 1 to 32 of
32
with 100 triples per page.
- BMS-955176 abstract "BMS-955176 is an experimental second generation HIV maturation inhibitor under development by Bristol-Myers Squibb for use in the treatment of HIV infection. By blocking the maturation of the virus, it prevents viral reproduction in host CD4+ T cells. Because it targets a different step of the viral lifecycle than medications that are currently FDA approved, it offers promise for individuals with virus that has become highly resistant to other classes of HIV drugs. First generation maturation inhibitors such as bevirimat were ineffective against some naturally occurring changes (polymorphisms) in the Gag protease polyprotein; BMS-955176 has been selected to better tolerate gag polymorphisms.".
- BMS-955176 wikiPageID "47310898".
- BMS-955176 wikiPageLength "3558".
- BMS-955176 wikiPageOutDegree "13".
- BMS-955176 wikiPageRevisionID "707971862".
- BMS-955176 wikiPageWikiLink Bevirimat.
- BMS-955176 wikiPageWikiLink Bristol-Myers_Squibb.
- BMS-955176 wikiPageWikiLink Category:Antiretroviral_drugs.
- BMS-955176 wikiPageWikiLink Category:Maturation_inhibitors.
- BMS-955176 wikiPageWikiLink Clinical_trial.
- BMS-955176 wikiPageWikiLink Conference_on_Retroviruses_and_Opportunistic_Infections.
- BMS-955176 wikiPageWikiLink Drug_development.
- BMS-955176 wikiPageWikiLink Food_and_Drug_Administration.
- BMS-955176 wikiPageWikiLink HIV.
- BMS-955176 wikiPageWikiLink HIV-1_protease.
- BMS-955176 wikiPageWikiLink Maturation_inhibitor.
- BMS-955176 wikiPageWikiLink Polymorphism_(biology).
- BMS-955176 wikiPageWikiLinkText "BMS-955176".
- BMS-955176 wikiPageUsesTemplate Template:Antiinfective-drug-stub.
- BMS-955176 wikiPageUsesTemplate Template:HIVpharm.
- BMS-955176 wikiPageUsesTemplate Template:Multiple_issues.
- BMS-955176 wikiPageUsesTemplate Template:Notability.
- BMS-955176 wikiPageUsesTemplate Template:Reflist.
- BMS-955176 wikiPageUsesTemplate Template:Technical.
- BMS-955176 subject Category:Antiretroviral_drugs.
- BMS-955176 subject Category:Maturation_inhibitors.
- BMS-955176 hypernym Inhibitor.
- BMS-955176 type Drug.
- BMS-955176 comment "BMS-955176 is an experimental second generation HIV maturation inhibitor under development by Bristol-Myers Squibb for use in the treatment of HIV infection. By blocking the maturation of the virus, it prevents viral reproduction in host CD4+ T cells. Because it targets a different step of the viral lifecycle than medications that are currently FDA approved, it offers promise for individuals with virus that has become highly resistant to other classes of HIV drugs.".
- BMS-955176 label "BMS-955176".
- BMS-955176 wasDerivedFrom BMS-955176?oldid=707971862.
- BMS-955176 isPrimaryTopicOf BMS-955176.